BACKGROUND
Sickle cell disease is recognized as a hypercoagulable state; however
the frequency and characteristics of venous thromboembolism in sickle cell
patients have not been well-defined.
PURPOSE
To establish the prevalence and risk factors for venous
thromboembolism in a large cohort of patients with sickle cell disease and
determine the relationship between venous thromboembolism and mortality.
METHODS
We performed a cross-sectional study of 404 sickle cell disease
patients cared for at the Sickle Cell Center for Adults at Johns Hopkins.
Demographic, sickle cell disease-specific comorbidity, and venous
thromboembolism data were collected on all patients.
RESULTS
101 patients (25%) had a history of venous thromboembolism
with a median age at diagnosis of 29.9 years. A history of
non-catheter-related venous thromboembolism was found in 18.8% of
patients. Sickle variant genotypes conferred a higher risk of
non-catheter-related venous thromboembolism compared to sickle cell anemia
genotypes (SS/Sβ0) (relative risk (RR) 1.77, 95%
confidence interval (CI) 1.18–2.66). Tricuspid regurgitant jet
velocity ≥ 2.5 m/s was also associated with non-catheter-related
venous thromboembolism (RR 1.65, CI 1.12–2.45). Thirty patients
(7.4%) died during the study period. Adjusting for all variables,
non-catheter-related venous thromboembolism was independently correlated
with death (RR 3.63, CI 1.66–7.92).
CONCLUSION
Venous thromboembolism is common in adults with sickle cell disease.
Sickle variant genotypes and tricuspid regurgitant jet velocity ≥
2.5m/s are associated with non-catheter-related venous thromboembolism. In
addition, non-catheter-related venous thromboembolism appears to be an
independent risk factor for death in our cohort. These results suggest that
disease-specific prophylaxis and treatment strategies for venous
thromboembolism should be investigated in sickle cell disease patients.